Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05882318 · ClinicalTrials.gov registry record · NA
Effectiveness of eCoin at Sensory and Subsensory Amplitudes
A NA study, sponsored by Valencia Technologies Corporation.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT05882318 is a NA study that has completed, run by Valencia Technologies Corporation. The registered enrollment target is 38 participants.
The verdict
NCT05882318, a NA study, has completed, sponsored by Valencia Technologies Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The goal of this prospective, multi-center, double-blinded randomized controlled is to learn about effectiveness and QOL with eCoin at two different amplitude settings in subjects with urge urinary incontincence (UUI). The main question it aims to answer is: * The reduction in UUI episodes per day on a 3-day voiding diary in both groups after 3 months of therapy Participants will be implanted with the eCoin device and randomized to either a sensory or subsensory stimulation group and complete voiding diaries and patient reported-outcomes through 3 months of therapy. After 3 months, subjects will be unblinded and reprogramming will be offered. Subjects will be followed for an additional month to a total of 4 months.
Interventions
- DEVICE eCoin Peripheral Neurostimulator System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2024-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05882318
The ClinicalTrials.gov registry entry for NCT05882318 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valencia Technologies Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eCoin Peripheral Neurostimulator System is the first listed.
NCT05882318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05882318 about?
NCT05882318 is a clinical study titled "Effectiveness of eCoin at Sensory and Subsensory Amplitudes". The goal of this prospective, multi-center, double-blinded randomized controlled is to learn about effectiveness and QOL with eCoin at two different amplitude settings in subjects with urge urinary incontincence (UUI). The main question it aims to answer is: * The reduction in UUI episodes per day ...
What is the current status of trial NCT05882318?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2023-06-06. Estimated completion is 2024-05-14.
What interventions are being tested in trial NCT05882318?
The interventions under investigation include: eCoin Peripheral Neurostimulator System (DEVICE).
Who is sponsoring clinical trial NCT05882318?
This trial is sponsored by Valencia Technologies Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.